NCT01361347

Safety of Oral Immunotherapy for Cow's Milk Allergy in School-aged Children

Phase 4 Study: Milk Oral Immunotherapy for Cow's Milk Allergy in School-aged Children

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 28 (actual)
• Sponsor: Tampere University Hospital · Academic / Other
• Sex: All
• Age: 6 Years – 16 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to study the number of Participants with Adverse Events as a Measure of Safety and Tolerability.

Detailed description

Eligibility criteria: Age 6 - 16 yrs * IgE-mediated milk allergy * and milk provocation within 3 months prior to or an documented accidental milk contact with clear immediate symptoms Outcome measures: * number of patients with successful desensitization (195 - 200 ml milk per day) * number of patients with adverse events

Conditions

• Milk Allergy
• Anaphylaxis

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	milk	milk for milk allergic children (1:25 dilution, whole milk)

Timeline

• Start date: 2008-02-01
• Primary completion: 2016-12-01
• Completion: 2016-12-01
• First posted: 2011-05-26
• Last updated: 2017-01-04

Locations

1 site across 1 country: Finland